These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 329423)

  • 21. Effect of delta 9-tetrahydrocannabinol on intraocular pressure after removal of autonomic input.
    Colasanti BK; Powell SR
    J Ocul Pharmacol; 1985; 1(1):47-57. PubMed ID: 2851632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of the cardiac conditioned response by delta-9-tetrahydrocannabinol: a comparison with other drugs.
    McLendon DM; Harris RT; Maule WF
    Psychopharmacology (Berl); 1976 Nov; 50(2):159-63. PubMed ID: 826956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human pharmacology of 1S and 1R enantiomers of delta-3-tetrahydrocannabinol.
    Hollister LE; Gillespie HK; Mechoulam R; Srebnik M
    Psychopharmacology (Berl); 1987; 92(4):505-7. PubMed ID: 2819920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade.
    Kanakis C; Pouget JM; Rosen KM
    Circulation; 1976 Apr; 53(4):703-7. PubMed ID: 1253395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between delta-9-tetrahydrocannabinol and indomethacin.
    Green K; Kearse EC; McIntyre OL
    Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
    Haney M; Rabkin J; Gunderson E; Foltin RW
    Psychopharmacology (Berl); 2005 Aug; 181(1):170-8. PubMed ID: 15778874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimethylheptyl-delta 6a-10a-tetrahydrocannabinol: effects after parenteral administration to man.
    Sidell FB; Pless JE; Neitlich H; Sussman P; Copelan HW; Sim VM
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):867-73. PubMed ID: 4571010
    [No Abstract]   [Full Text] [Related]  

  • 28. Involvement of central alpha-adrenoceptors in the hypotensive and bradycardic effects of (--)-delta 9-trans-tetrahydrocannabinol.
    Lokhandwala MF; Pariani HK; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1977 Mar; 42(2):107-12. PubMed ID: 191263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of delta-9-tetrahydrocannabinol on ophthalmotonus].
    Cuendet JF; Shapiro D; Calanca A; Faggioni R; Ducrey N
    Ophthalmologica; 1976; 172(2-3):122-7. PubMed ID: 1256748
    [No Abstract]   [Full Text] [Related]  

  • 30. A psychological and physiological evaluation of the effects of intravenous diazepam.
    Kelly D; Pik R; Chen CN
    Br J Psychiatry; 1973 Apr; 122(569):419-26. PubMed ID: 4577947
    [No Abstract]   [Full Text] [Related]  

  • 31. Decrease in intraocular pressure produced by I.V. or conjunctival diazepam.
    Pino Capote JA
    Br J Anaesth; 1978 Aug; 50(8):865. PubMed ID: 678378
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of synthetic cannabinoids on elevated intraocular pressure.
    Tiedeman JS; Shields MB; Weber PA; Crow JW; Cocchetto DM; Harris WA; Howes JF
    Ophthalmology; 1981 Mar; 88(3):270-7. PubMed ID: 7015221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diazepam and intraocular pressure.
    Al-Abrak MH
    Br J Anaesth; 1978 Aug; 50(8):866. PubMed ID: 678379
    [No Abstract]   [Full Text] [Related]  

  • 34. Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.
    Hart CL; Haney M; Vosburg SK; Comer SD; Foltin RW
    Psychopharmacology (Berl); 2005 Sep; 181(2):237-43. PubMed ID: 15830233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men.
    Tashkin DP; Shapiro BJ; Frank IM
    N Engl J Med; 1973 Aug; 289(7):336-41. PubMed ID: 4718513
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1975 Sep; 18(3):287-97. PubMed ID: 1164818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of delta9-tetrahydrocannabinol with oxymorphone or pentobarbital: Effects on ventilatory control and cardiovascular dynamics.
    Johnstone RE; Lief PL; Kulp RA; Smith TC
    Anesthesiology; 1975 Jun; 42(6):674-84. PubMed ID: 48348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking.
    Kelly TH; Foltin RW; Emurian CS; Fischman MW
    J Exp Anal Behav; 1994 Mar; 61(2):203-11. PubMed ID: 8169569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice.
    Thorat SN; Bhargava HN
    Eur J Pharmacol; 1994 Jul; 260(1):5-13. PubMed ID: 7957626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine.
    Estrada U; Brase DA; Martin BR; Dewey WL
    Life Sci; 1987 Jul; 41(1):79-87. PubMed ID: 3037218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.